LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
1-Year Est. Return 2.97%
This Quarter Est. Return
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$282M
AUM Growth
+$5.03M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$29.3M
2
+$11.1M
3
+$2.36M
4
GHRS icon
GH Research
GHRS
+$1.53M
5
CRBU icon
Caribou Biosciences
CRBU
+$1.33M

Top Sells

1
+$4.52M
2
+$3.68M
3
+$129K
4
PVLA
Palvella Therapeutics
PVLA
+$101K
5
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$31.7K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$89.6M 31.75%
1,793,866
+587,159
2
$63.8M 22.59%
5,187,191
+2,000
3
$39.2M 13.9%
6,880,527
4
$28.1M 9.95%
4,195,894
+229,168
5
$26M 9.22%
5,224,600
6
$17.4M 6.15%
6,202,374
+3,974,079
7
$6.88M 2.44%
410,830
+33,507
8
$5.9M 2.09%
421,348
+168,467
9
$1.91M 0.68%
862,279
+21,516
10
$1.33M 0.47%
+680,189
11
$708K 0.25%
+271,177
12
$621K 0.22%
37,436
-6,063
13
$278K 0.1%
17,400
14
$241K 0.09%
45,806
-4,167
15
$206K 0.07%
8,231
-1,269
16
$51K 0.02%
+14,751
17
$32.5K 0.01%
+19,028
18
$30.4K 0.01%
16,194
19
– –
-492,103
20
– –
-3,800
21
– –
-167,317